Tarsadia Investments
Tarsadia Investments is a multi-strategy investment firm that makes long-term, high-conviction investments across venture & growth equity, life sciences, real estate and public/private equities. The firm emphasizes active, multidisciplinary support for portfolio companies and uses a permanent capital base and flexible mandate to back companies across stages and sectors. Site-reported metrics: $2B+ AUM, 28 portfolio companies, 30+ years operating history, and 20 investment professionals.
Tarsadia Investments
Newport Beach, California, United States, North America
Services
Venture & Growth Equity
Direct equity investments in companies from Series A and beyond; typical check sizes reported at $5M–$75M. Can lead or participate in syndicates and follows thesis-driven investments.
Life Sciences Investing & Operational Support
Equity investments and active partnership with life sciences companies across drug delivery, preclinical and early clinical-stage assets in CNS, inflammation/immunology, oncology and biosimilars; includes access to industry expertise and multi-year active support.
Real Estate Investment and Development
Direct real estate acquisitions and development with a focus on identifying hidden value and executing rapidly; firm-reported completion of $1B+ in hotel acquisitions and development.
Public & Private Equity Trading (Tarsadia Capital)
Investment management vehicle (Tarsadia Capital) with a flexible, long-duration mandate for public and private equities and commodities globally.
Active Portfolio Support & Network Access
Beyond capital, the firm provides time, talent, operational experience, industry expertise and network access to portfolio companies; the firm emphasizes long-term partnerships and multidisciplinary support.
Venture & Growth Equity
Direct equity investments in companies from Series A and beyond; typical check sizes reported at $5M–$75M. Can lead or participate in syndicates and follows thesis-driven investments.
Life Sciences Investing & Operational Support
Equity investments and active partnership with life sciences companies across drug delivery, preclinical and early clinical-stage assets in CNS, inflammation/immunology, oncology and biosimilars; includes access to industry expertise and multi-year active support.
Real Estate Investment and Development
Direct real estate acquisitions and development with a focus on identifying hidden value and executing rapidly; firm-reported completion of $1B+ in hotel acquisitions and development.
Public & Private Equity Trading (Tarsadia Capital)
Investment management vehicle (Tarsadia Capital) with a flexible, long-duration mandate for public and private equities and commodities globally.
Active Portfolio Support & Network Access
Beyond capital, the firm provides time, talent, operational experience, industry expertise and network access to portfolio companies; the firm emphasizes long-term partnerships and multidisciplinary support.
Portfolio
Developer and manufacturer of generic and specialty pharmaceutical products.
#Pharmaceuticals / Specialty & Generic Pharma
Research and development company focused on discovery and development of new chemical and biological entities across oncology, pain and inflammation.
#Biopharmaceutical R&D
Tech-enabled platform for managing and renting high-end vacation properties; Tarsadia co-led a $160M Series B.
#Hospitality / Short-term rentals (Proptech)
Insurance infrastructure platform connecting carriers, brokers and tech platforms; involved in a Series A extension to US$210M.
#Insurtech / Insurance distribution infrastructure
Digital securities and fund investment platform using Web3 technologies, initial focus on mortgage issuance and securitization.
#Digital securities / Fintech (mortgage issuance focus)
Provider of installation, maintenance and repair services for gates, doors, access control and surveillance systems.
#Access control / Physical security services
Developer and manufacturer of generic and specialty pharmaceutical products.
#Pharmaceuticals / Specialty & Generic Pharma
Research and development company focused on discovery and development of new chemical and biological entities across oncology, pain and inflammation.
#Biopharmaceutical R&D
Tech-enabled platform for managing and renting high-end vacation properties; Tarsadia co-led a $160M Series B.
#Hospitality / Short-term rentals (Proptech)
Insurance infrastructure platform connecting carriers, brokers and tech platforms; involved in a Series A extension to US$210M.
#Insurtech / Insurance distribution infrastructure
Digital securities and fund investment platform using Web3 technologies, initial focus on mortgage issuance and securitization.
#Digital securities / Fintech (mortgage issuance focus)
Provider of installation, maintenance and repair services for gates, doors, access control and surveillance systems.
#Access control / Physical security services